The company
Qiagen N.V. Common Shares
QGEN · NYSE
QGEN stood above a rising 150-day average in 11 of the last 52 weekly readings, and has been out of that trend for the last 34 weeks. It is 21.2% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 34
- Industry in uptrend
- 18% -14 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 16
- Institutions holding
- 320 (-6)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 11 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
16 disclosed lines: House 16, Senate 0, executive 0; 4 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Peter Welch House: U.S. House ClerkVT00 | sold | $1k–$15k | 24 Mar 2020filed 3 Apr 2020 |
| Peter Welch House: U.S. House ClerkVT00 | bought | $1k–$15k | 27 Feb 2020filed 10 Mar 2020 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | sold | $1k–$15k | 8 Oct 2019filed 8 Nov 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | soldspouse | $15k–$50k | 8 Oct 2019filed 8 Nov 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | soldspouse | $1k | 8 Oct 2019filed 7 Nov 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | boughtspouse | $1k–$15k | 13 Sep 2019filed 21 Sep 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | bought | $1k–$15k | 13 Sep 2019filed 21 Sep 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | boughtspouse | $0k | 13 Sep 2019filed 21 Sep 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | boughtspouse | $1k–$15k | 12 Sep 2019filed 21 Sep 2019 |
| Alan S. Lowenthal House: U.S. House ClerkCA47 | boughtspouse | $0k | 12 Sep 2019filed 21 Sep 2019 |
| Donna E. Shalala House: U.S. House ClerkFL27 | sold | $1k–$15k | 23 Jan 2019filed 27 Apr 2020 |
| Donna E. Shalala House: U.S. House ClerkFL27 | sold | $1k–$15k | 9 Jan 2019filed 27 Apr 2020 |
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026 | 12,406,763$484.2M | -1,957,540−13.6% |
| PRINCIPAL FINANCIAL GROUP INCadded · filed 4 Aug 2026 | 6,648,681$260.0M | +6,643,158+120281.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 6,209,904$240.2M | +103,629+1.7% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 5,905,678$230.9M | +655,217+12.5% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 5,042,391$197.2M | +851,478+20.3% |
| EARNEST PARTNERS LLCadded · filed 13 Aug 2026 | 4,573,455$178.8M | +704,966+18.2% |
| GOLDMAN SACHS GROUP INCadded · filed 14 Aug 2026 | 4,443,674$173.7M | +3,052,347+219.4% |
| NORGES BANKnew · filed 12 Aug 2026 | 4,325,135$168.0M | +4,325,135 |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 3,845,605$150.4M | +3,247,768+543.3% |
| Amundireduced · filed 11 Aug 2026 | 3,683,362$144.0M | -1,074,319−22.6% |
News
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.